keyword
https://read.qxmd.com/read/20426705/treating-multiple-sclerosis-with-fingolimod-or-intramuscular-interferon
#1
COMMENT
Carlo Pozzilli, Luca Prosperini, Giovanna Borriello
The 12-month, double-blind TRANSFORMS study compared two dose regimens of oral fingolimod (0.5 and 1.25 mg/day) with intramuscular (i.m.) interferon beta-1a (IFN-beta-1a) administered once weekly at dosage of 30 microg in a study population of 1292 patients with relapsing remitting multiple sclerosis. Both doses of fingolimod were shown to be superior to i.m. IFN-beta-1a in reducing relapse rate and disease activity as detected by magnetic resonance imaging, while no significant effect on disability progression was observed...
August 2010: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/16981033/parametric-evaluation-of-methotrimeprazine-midazolam-ketamine-and-methotrimeprazine-midazolam-ketamine-xylazine-combination-in-dogs
#2
JOURNAL ARTICLE
Gustavo José Von Glehn dos Santos, Eduardo Hatschbach, Ewaldo de Mattos Júnior, Flávio Massone
PURPOSE: To evaluate the parameters of dogs anesthetized by different dissociative drugs protocols through continuous intravenous infusion. METHODS: Thirty healthy dogs of both sexes were assigned randomly to three groups (G1, G2, and G3). G1 was administered with methotrimeprazine as a pre-anesthetic medication, intravenously midazolam-ketamine as bolus for induction and midazolam-ketamine by continuous intravenous infusion for a 60 minute-period of maintenance...
September 2006: Acta Cirúrgica Brasileira
https://read.qxmd.com/read/15112138/-prenatal-diagnosis-and-outcome-of-fetal-bradyarrhythmias
#3
COMPARATIVE STUDY
M Tollens, K T M Schneider, D Lang, R Oberhoffer
BACKGROUND: The purpose of this study was to evaluate the clinical outcome of fetuses with bradyarrhythmias or complete heart block (CHB) in the setting of fetal structural heart disease (CHD) or of maternal collagenosis with and without treatment. METHODS: A retrospective analysis of echocardiographic studies performed in 14 fetuses (mean gestational age 25.5, range 19 - 36 weeks) referred for exclusion or diagnosis of bradyarrhytmias was performed. Maternal SS-A/Ro and SS-B/La antibodies were measured by ELISA...
April 2004: Zeitschrift Für Geburtshilfe und Neonatologie
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.